---
title: BioAgile Therapeutics vs SMO India Clinical Research Pvt Ltd
slug_a: bioagiletherapeutics
slug_b: smo-india
site: cro
review_signal_gate: closed
canonical_path: /compare/bioagiletherapeutics/smo-india
---

# BioAgile Therapeutics vs SMO India Clinical Research Pvt Ltd

Side-by-side profile data from each company listing on this directory.

## BioAgile Therapeutics

- Profile: [/companies/bioagiletherapeutics](/companies/bioagiletherapeutics)

BioAgile Therapeutics — ISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech.

Services: 10. Modalities: 0. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (10).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)

## SMO India Clinical Research Pvt Ltd

- Profile: [/companies/smo-india](/companies/smo-india)

SMO India Clinical Research Pvt Ltd — CDSCO-registered CRO with 25+ years of clinical trial experience across Phase I–IV studies in India. Specializes in site management, clinical operations, and regulatory affairs across diverse therapeutic areas.

Services: 6. Modalities: 0. Indications: 0. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (6).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)